NASDAQ:EPOC Epocrates (EPOC) Stock Price, News & Analysis → Have You Seen Elon’s New A.I. Device? (Picture Inside) (From InvestorPlace) (Ad) Free EPOC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume228,735 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Epocrates alerts: Email Address Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. About Epocrates Stock (NASDAQ:EPOC)Epocrates, Inc. (Epocrates) is a provider of mobile drug reference tools and electronic health records to healthcare professionals and interactive services to the healthcare industry. As of December 31, 2011, its user network consists of well over one million healthcare professionals, including approximately 340,000, or more than 50% of United States physicians. The Company offers its products on major United States mobile platforms, including Apple iOS, Android and BlackBerry. Epocrates operates in two segments: Subscriptions and Interactive Services, and Electronic Health Records. It uses brand names include DocAlert, Epocrates, Epocrates Honors, Epocrates ID, Epocrates Lab, Epocrates MedTools, Epocrates Rx, Epocrates Rx Pro, Epocrates Dx, Epocrates QuickSurvey, Epocrates QuickRecruit, Epocrates MedInsight, EssentialPoints and MedCafe. In October 2011, it launched a redesign of the drug reference tool to create a new platform that provides healthcare professionals.Read More Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. EPOC Stock News HeadlinesFebruary 8, 2024 | forbes.comGOLO Diet Review (2024): Cost, Benefits And MoreFebruary 6, 2024 | finance.yahoo.comathenahealth Names David Minkin General Manager of epocratesMay 3, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.November 1, 2023 | benzinga.comepocrates Inaugural Healthcare Media Leadership Summit Explores the Future of Healthcare MarketingOctober 17, 2023 | finance.yahoo.comGalileo and Wellcare Forge a New Partnership in Maine Benefitting Thousands of Medicare Advantage MembersJune 22, 2023 | finance.yahoo.comQuestex’s Fierce Pharma Announces the 2023 Fierce Pharma Marketing Awards FinalistsJune 21, 2023 | fortune.comThe ADHD drug shortage is spreading as supplies of a popular alternative to Adderall run worryingly lowMay 14, 2023 | msn.comMeloxicam Explained: Uses, Dosage, And Side EffectsMay 3, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.May 11, 2023 | marketwatch.comHealthcare Mobile Application Market SWOT Analysis by Leading Key Players Epocrates, 8FIT, Fitbit, NikeMay 9, 2023 | marketwatch.com2030, Drug Discovery Software Market Growth | Future Prospects and Competitive AnalysisMay 9, 2023 | marketwatch.comMobile Medical Applications Market Research, 2030May 5, 2023 | marketwatch.comE-Health Services Market - Global Industry Analysis, Size, Growth, Trends and Forecast 2023 to 2030 with an impacting CAGR 9%May 3, 2023 | marketwatch.comConnected Health M2M Market Booming Industry Growth, Research Scope, Advance Technology and Innovations by 2031April 29, 2023 | marketwatch.comDrug Discovery Software Market Global Analysis 2023-2030April 27, 2023 | finance.yahoo.comepocrates and Cognito Therapeutics Join Forces to Deliver Video Messaging to Healthcare ProfessionalsApril 6, 2023 | marketwatch.comDrug Discovery Software Market Size, Trends and Forecast 2030March 30, 2023 | marketwatch.comeHealth Market Trends, Industry Demand and Scope, Top Players Analysis, Forecast 2023 - 2031March 30, 2023 | finance.yahoo.comGlobal Clinical Decision Support Systems Market Size To Worth USD 10.2 Billion by 2030 | CAGR of 9.1%March 22, 2023 | marketwatch.comE-Health Services Market Top Players and Forecast till 2031March 17, 2023 | marketwatch.comeHealth Market Concretely Analyze Report 2023 To 2029March 2, 2023 | finance.yahoo.comepocrates Celebrates Sizable 2022 Growth, Driven by New Design, Tools, and Guidelines to Improve the Clinician ExperienceFebruary 22, 2023 | finance.yahoo.comDespite Widespread Interest in CPR Certification, Most Americans Lack Awareness on Education and Training, New Research ShowsFebruary 22, 2023 | marketwatch.comDrug Discovery Software Market (New Insights Report) By 2023 which is Booming Strong Growth in the Globe till 2028February 19, 2023 | marketwatch.comDrug Discovery Software Market Share : Industry Trends, Growth, Size and Segmentation by 2023 to 2028February 16, 2023 | marketwatch.comHealthcare Mobile Application Market by 360 Market Updates Reports with Top Featured Companies Dominating the IndustryFebruary 15, 2023 | marketwatch.comE-Health Services Market 2023 : Detailed analysis of Industry Potential Growth attractive Valuation and growth Forecast up to 2028See More Headlines Receive EPOC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Epocrates and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:EPOC CUSIPN/A CIK1096738 Webwww.epocrates.com Phone+1-415-4163500FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (NASDAQ:EPOC) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersThe AI stock to buy right nowStockEarningsCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmith$5,000 Gold?Stansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBill Gates is all about this tiny $2 stockTimothy SykesTruth about Trump you’ve never heardPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Epocrates, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
